NCT04584736View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

July 16, 2020

Study Completion Date

October 12, 2020

Conditions
Primary Hypercholesterolemia
Interventions
DRUG

Livalo, Ezetrol

Pitavastatin+Ezetimibe Pitavastatin

Trial Locations (1)

134-701

Gangdong Sacred Heart Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY